Decoding FDA DTC Policy: Part 2 – What are user comprehension studies? And are pharmacogenetic test report requirements different than previous FDA regulations?

Decoding FDA DTC Policy: Part 2 – What are user comprehension studies? And are pharmacogenetic test report requirements different than previous FDA regulations?

What Are User Comprehension Studies and Why are they Required by the FDA?

Unlike tests that are overseen by health care professionals where a conversation may take place about the meaning of results, direct-to-consumer tests bypass the traditional patient-doctor relationship and deliver results directly to patients (or consumers).  A well-known example of a direct-to-consumer test is a pregnancy test that one may purchase at any pharmacy or similar retail store…

read more
Decoding FDA DTC Policy: Part 1 – Pharmacogenetics Are Here!

Decoding FDA DTC Policy: Part 1 – Pharmacogenetics Are Here!

While many of us were heading out to dish out candy (or tricks) to local goblins and superheroes this past Halloween, the FDA rounded out their suite of De Novo reclassification orders on DTC genetic testing.  The latest announcement adds Personal Genome Service Pharmacogenetic Reports (PGSPR) to the existing regulations for Carrier Screening and Genetic Health Risk (GHR) tests (including a specific case of Genetic Health Risk Report for BRCA1/BRCA2)…

read more
FDA Genetic Health Assessment Ruling: Decoded

FDA Genetic Health Assessment Ruling: Decoded

Trying to read and understand the latest FDA release on personal genetic testing (or what they are now calling Genetic Health Assessments)?  Wish that they could indent when they use multi-level outlines?  We have created a version that may be a bit easier to read and understand…

read more